Polymeropoulos Mihael Hristos
President and CEO
Polymeropoulos Mihael Hristos has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 4, 2026.
On the most recent filing, Polymeropoulos Mihael Hristos is listed as President and CEO at Vanda Pharmaceuticals Inc. Inside the rolling window, Polymeropoulos Mihael Hristos reported no open-market purchases and 1 open-market sale totaling $1.3M in VNDA.
Companies traded
Other insiders at VNDA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Polymeropoulos Mihael Hristos made?
Polymeropoulos Mihael Hristos has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Polymeropoulos Mihael Hristos trade?
Polymeropoulos Mihael Hristos has filed SEC Form 4 disclosures for 1 company, including VNDA.
When was Polymeropoulos Mihael Hristos's most recent SEC Form 4 filing?
Polymeropoulos Mihael Hristos's most recent SEC Form 4 filing on Tracefour is dated Mar 4, 2026.
What is Polymeropoulos Mihael Hristos's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Polymeropoulos Mihael Hristos is listed as President and CEO.
What is Polymeropoulos Mihael Hristos's total buy and sell value in the current window?
Inside the rolling retention window, Polymeropoulos Mihael Hristos bought $0 and sold $1.3M based on SEC Form 4 filings.
What was Polymeropoulos Mihael Hristos's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 156,235 VNDA shares on 2026-03-02, worth $1.3M, per SEC Form 4 filings.